Richard Scott Struthers, President & CEO at Crinetics Pharmaceuticals, Inc. (CRNX), sold 277,286 shares at $25.42 ($7.4M) on 2022-04-13, disclosed to the SEC on 2022-04-15.
Open-market sale of $7.4M CRNX by President & CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.42 | 24,674 | $627K | 8.4% |
| 2 | $25.42 | 24,674 | $627K | 8.4% |
| 3 | $26.52 | 44,793 | $1.2M | 16.0% |
| 4 | $26.52 | 44,793 | $1.2M | 16.0% |
| 5 | $27.53 | 69,176 | $1.9M | 25.6% |
| 6 | $27.53 | 69,176 |
| $1.9M |
| 25.6% |
| Total | $26.83 avg | 277,286 | $7.4M | 100% |
| Filing → |
| CRNX | SELL | 2025-03-21 | $1.2M | — | Filing → |
| CRNX | SELL | 2024-12-04 | $576K | — | Filing → |
| CRNX | SELL | 2024-05-10 | $10.6M | — | Filing → |